Antidepressant drugs and the cardiovascular system: A comparison of tricylics and selective serotonin reuptake inhibitors and their relevance for the treatment of psychiatric patients with cardiovascular problems

Journal of Psychopharmacology

Volumn 11, Issue 1, 1997, Pages 83-92

  Coupland, Nick ^a   Wilson, Susan ^b   Nutt, David ^b  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; CLONIDINE; DESIPRAMINE; DIGOXIN; FLECAINIDE; FLUOXETINE; FLUVOXAMINE; IMIPRAMINE; METOPROLOL; MONOAMINE OXIDASE INHIBITOR; MORACIZINE; PAROXETINE; PINDOLOL; PROPRANOLOL; SEROTONIN UPTAKE INHIBITOR; THEOPHYLLINE; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE; WARFARIN;

CARDIOVASCULAR DISEASE; CARDIOVASCULAR EFFECT; DEPRESSION; DRUG METABOLISM; DRUG PROTEIN BINDING; HEADACHE; HEART ARRHYTHMIA; HEART INFARCTION; HEART RATE; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; MENTAL PATIENT; ORTHOSTATIC HYPOTENSION; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; RISK; TACHYCARDIA; THORAX PAIN;

ANTIDEPRESSIVE AGENTS, TRICYCLIC; ARRHYTHMIA; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; CORONARY DISEASE; HEART RATE; HEMODYNAMIC PROCESSES; HUMANS; HYPOTENSION, ORTHOSTATIC; MENTAL DISORDERS; SEROTONIN UPTAKE INHIBITORS;

EID: 0031004217     PISSN: 02698811     EISSN: None     Source Type: Journal    
DOI: 10.1177/026988119701100118     Document Type: Review

References (117)

1. Ahern D K, Gorkin L, Anderson J L, Tierney C, Hallstrom A, Ewart C, Capone R J, Schron E, Kornfeld D, Herd J A (1990) Biobehavioural variables and mortality or cardiac arrest in the Cardiac Arrhythmia Pilot Study (CAPS). Am Cardiol 66: 59-62
2. Askelrod S D, Gordon G, Ubel A F, Shannon D C, Barger C A, Cohen R J (1981) Power spectrum analysis of heart rate fluctuation: a quantitative probe of beat-to-beat cardiovascular control. Science 213: 220-222
3. 3 antagonist ondansetron reduces gastrointestinal side effects induced by a specific serotonin re-uptake inhibitor in man. J Psychopharmac 9: 137-141
4. Balogh S, Fitzpatrick D F, Hendricks S E, Paige S R (1993) Increases in heart rate variability with successful treatment in patients with major depressive disorder. Psychopharmac Bull 29: 201-206
5. Bannister S J, Houser V P, Hulse J D, Kisicki J C, Rasmussen J G (1989) Evaluation of the potential for interactions of paroxetine with diazepam, cimetidine, warfarin and digoxin. Acta Psychiat Scand 80 (Suppl): 102-106
6. Bench C J, Friston K J, Brown R G, Frackowiak R S J, Dolan R J (1993) Regional cerebral blood flow in depression measured by positron emmission tomography: the relationship with clinical dimensions. Psychol Med 23: 579-590
7. Benfield P, Ward A (1986) Fluvoxamine: a review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in depressive illness. Drugs 32: 313-334
8. Bergstrom R F, Lemberger L, Farid N A, Wolen R L (1988) Clinical pharmacology and pharmacokinetics of fluoxetine: a review. Br J Psychiat 153 (Suppl. 3): 47-50
9. Bigger J T J, Giardina EG V, Perel J M, Kantor S J, Glassman A H (1977) Cardiac antiarrhythmic effect of imipramine hydrochoride. N Engl J Med 296: 206-208
10. Blier P, Bergeron R (1995) The safety of concomitant use of sumatriptan and antidepressant treatments. J Clin Psychopharmac 15: 106-109
11. Boakes A J, Laurence D R, Teoh P C, Barar F S, Benedikter L T, Prichard B N (1973) Interactions between sympathomimetic amines and antidepressant agents in man. BMJ 1: 311-315
12. British National Formulary (1992) The Pharmaceutical Press: London, p. 468
13. Brosen K, Sjelbo E, Rasmussen B B (1993) Fluvoxamine is a potent inhibitor of cytochrome P450IA2. Biochem Pharmac 45: 1211-1214
14. Cannon R O, Quyyumi A A, Mincemoyer R (1994) Imipramine in patients with chest pain despite normal coronary angiograms. N Engl J Med 330: 1411-1417
15. Carney R M, Rich M W, Freedland K E, Saini J, te Velde A, Simeone C, Clark K (1988) Major depressive disorder predicts cardiac events in patients with coronary artery disease. Psychosom Med 50: 627-633
16. Casadei B, Piplis A, Sessa F, Conway J, Sleight P (1993) Low dose of scopolamine increases cardiac vagal tone in the acute phase of myocardial infarction. Circulation 88: 353-357
17. Celada P, Dolera M, Alvarez E, Artigas F (1992) Effects of acute and chronic treatment with fluvoxamine on extracellular and platelet serotonin in the blood of major depressive patients. J Affect Dis 25: 243-250
18. Christensen P, Thomsen H Y, Pedersen O L, Gram L F, Kragh-Sorensen P (1985) Orthostatic side effects of clomipramine and citalopram during treatment for depression. Psychopharmacology 86: 383-385
19. Coats A J S, Adamopoulos S, Radaelli A, McCance A, Meyer T E, Bernardi L, Solda P L, Davey P, Ormerod O, Forfar C (1992) Controlled trial of physical training in heart failure. Exercise performance, hemodynamics, ventilation and autonomic failure. Circulation 85: 2119-2131
20. Coull D S, Crooks J, Dingwall-Fordyce K (1970) A method of monitoring drugs for adverse reaction. II. Amitriptyline and cardiac disease. Eur J Clin Pharmac 3: 51-55
21. Coupland N J, Wilson S J, Bailey J E, Potokar J, Nutt D J (1994) A comparison of the effects of sertraline and clomipramine on postural blood pressure changes and heart rate and blood pressure variability. Eur Neuropsychoparmac 4: 294-295 (abstract)
22. Coupland N J, Wilson S J, Potokar J P, Bell C E, Bailey J E, Nutt D J (1995a) A comparison of the effects of phenelzine treatment with moclobemide treatment on cardiovascular reflexes. Int Clin Psychopharmac 10: 229-238
23. Coupland N J, Bailey J E, Wilson S J, Horvath R, Nutt D J (1995b) The effects of clonidine on cardiovascular responses to standing in healthy volunteers. Clin Autonom Res 5: 171-177
24. Coupland N J, Bailey J E, Potokar J, Bell CE, Lillywhite A R, Nutt D (1995c) Abnormal cardiovascular responses to standing in patients with panic disorder and social phobia. J Psychopharmac 9 (Suppl.): A19(Abstract)
25. Cusack B, Nelson A, Richelson E (1994) Binding of antidepressants to human brain receptors: focus on newer generation compounds. Psychopharmacology 114: 559-565
26. Dalack G W, Roose S P (1991) Perspectives on the relationship between cardiovascular disease and affective disorder. J Clin Psychiat 51 (Suppl. 7): 4-9
27. De Mey C, Schroeter V, Butzer R, Roll S, Belz G G (1995) Method specificity of non-invasive blood pressure measurement: oscillometry and finger pulse methods vs acoustic methods. Br J Clin Pharmac 40: 291-297
28. Dimier-David L, Billon N, Costagliola D, Jaillon P, Funck-Brentano C (1994) Reproducibility of non-invasive measurement and of short-term variability of blood pressure and heart rate in healthy volunteers. Br J Clin Pharmac 38: 109-115
29. Eckberg D L, Drabinsky M, Braunwald E (1971) Defective cardiac parasympathetic control in patients with heart disease. N Engl J Med 285: 877-883
30. Ewing D J, Campbell I W, Clarke B F (1980) Assessment of cardiovascular effects in diabetic autonomic neuropathy and prognostic implications. Ann Intern Med 92: 308-311
31. Feder R (1991) Bradycardia and syncope induced by fluoxetine. J Clin Psychiat 52: 138-139
32. Ferguson J, Khan A, Kucharik R, Leventer S, Cucci C (1994) A placebo-controlled comparative study of the effects on blood pressure and antidepressant efficacy of venlafaxine and imipramine. Neuropsychopharmacology 10: 165S(abstract)
33. Fisch C (1985) Effect of fluoxetine on the ECG. J Clin Psychiat 46: 42-44
34. Fisch C, Knoebel S B (1992) ECG findings in sertraline depression trials. Drug Invest 4: 305-312
35. Frasure-Smith N, Lesperance F, Talajic M (1993) Depression following myocardial infarction: impact on 6 month survival. JAMA 270: 1819-1825
36. Fritze J, Unsorg B, Lanczik M (1991) Interaction between carbamazepine and fluvoxamine. Acta Psychiat Scand 84: 583-584
37. Glassman A H, Bigger J T Jr (1981) Cardiovascular effects of therapeutic doses of tricyclic antidepressants. Archs Gen Psychiat 38: 815-820
38. Glassman A H, Johnson L L, Giardina E G V, Walsh B T, Roose S P, Cooper T B, Bigger J T Jr (1983) The use of imipramine in depressed patients with congestive cardiac failure. JAMA 250: 1997-2001
39. Glassman A H, Roose S P, Bigger J T (1993) The safety of tricyclic antidepressants in cardiac patients: risk-benefit reconsidered. JAMA 269: 2673-2675
40. Goulet J, Perusse R, Turcotte J (1992) Contraindications to vasoconstrictors in dentistry: part III. Pharmacologic interactions. Oral Surg Oral Med Oral Pathol 74: 692-697
41. Green A R (1990) The effects of antidepressant drugs on noradrenergic receptor mechanisms in the central nervous system. In Heal D J, Marsden CA (eds), The pharmacology of noradrenaline in the central nervous system. Oxford University Press, Oxford, pp. 316-348
42. Greenblatt D J, Preskorn S H, Cotreau M M, Horst W D, Harmatz J S (1992) Fluoxetine impairs clearance of alprazolam but not of clonazepam. Clin Pharmac Ther 52: 479-486
43. Grossman P, Karemaker J, Wieling W (1991) Prediction of tonic parasympathetic cardiac control using respiratory sinus arrhythmia: the need for respiratory control. Psychophysiology 28: 201-216
44. Grubb B P, Samoil D, Kosinski D, Kip K, Brewster P (1994a) Use of sertraline hydrochloride in the treatment of refractory neurocardiogenic syncope in children and adolescents. J Am Coll Cardiol 24: 490-494
45. Grubb B P, Samoil D, Kosinski D, Wolfe D, Lorton M, Madu E (1994b) Fluoxetine hydrochloride for the treatment of severe refractory orthostatic hypotension. Am J Med 97: 366-368
46. Gundersen H J G, Neubauer B (1977) A long-term diabetic autonomic nervous abnormality. Diabetalogia 13: 137-140
47. Harvey A T, Preskorn S H (1995) Interactions of serotonin reuptake inhibitors with tricyclic antidepressants. Archs Gen Psychiat 52: 783-784
48. Hayward C, Clark D B, Barr Taylor C (1990) Panic disorder, anxiety, and cardiovascular risk. In Ballenger J C (ed.), Clinical aspects of panic disorder. Wiley-Liss, New York, pp. 99-110
49. Hillis L D, Lange R A (1991) Serotonin and acute ischaemic heart disease. N Engl J Med 324: 688-689
50. Holliday S M, Benfield P (1995) Venlafaxine: a review of its pharmacology and therapeutic potential in depression. Drugs 49: 280-294
51. Imholz B P M, Settels J J, van der Meiracker A H, Wesseling K H, Wieling W (1990) Non-invasive continuous finger blood pressure measurement during orthostatic stress compared to intra-arterial pressure. Cardiovasc Res 24: 214-221
52. Iruela L M (1994) Sudden chest pain with sertraline (letter). Lancet 343: 1106
53. Jakobsen J, Hauksson P, Vestergaard P (1984) Heart rate variation in patients treated with antidepressants, an index of anti-cholinergic effects. Psychopharmacology 84: 544-548
54. Kleiger R E, Miller A B, Bigger J T, Moss A J (1987) Decreased heart rate variability and its association with increased mortality after myocardial infarction. Am J Cardiol 59: 256-262
55. Klein E, Cnaani E, Harel T, Braun S, Ben-Haim S (1995) Altered heart rate variability in panic disorder patients. Biol Psychiat 37: 18-24
56. Kobinger W, Walland A (1971) Involvement of adrenergic receptors in central vagus activity. Eur J Pharmac 16: 120-122
57. Levenson J L, Hamer R M, Rossiter L F (1990) Relation of psychopathology in general medical inpatients to use and costs of service. Am J Psychiat 147: 1498-1503
58. Lin K, Poland R E (1995) Ethnicity, culture and psychopharmacology. In Bloom F E, Kupfer D J (eds), Psychopharmacology: the fourth generation of progress. Raven Press, New York, pp. 1907-1917
59. Low PA (1993) Autonomic nervous system function. J Clin Neurophys 10: 14-27
60. Mangano D T, Browner W S, Hollenberg M, Li J, Tateo I M (1992) Long-term prognosis following non-cardiac surgery. JAMA 268: 233-239
61. McCall R B, Clement M E (1994) Role of serotonin1A and serotonin2 receptors in the central regulation of the cardiovascular system. Pharmac Rev 46: 231-243
62. Middleton H C, Nutt D J (1988) Heart rate response to standing as an index of adaptation to imipramine during treatment of panic disorder. Hum Psychopharmac 3: 191-194
63. Middleton H C, Nutt D J, Anastassiades P (1988) Evidence that imipramine-induced postural hypotension may be centrally mediated. Hum Psychopharmac 3: 181-190
64. Middleton H C, Ashby M, Robbins T W (1994) Reduced plasma noradrenaline and abnormal heart rate variability in resting panic disorder patients. Biol Psychiat 36: 847-849
65. Montgomery S A, Kasper S (1995) Comparison of compliance between serotonin reuptake inhibitors and tricyclic antidepressants: a meta-analysis. Int Clin Psychopharmac 9 (Suppl. 4): 33-40
66. Mukerji V, Beitman B D, Alpert M A, Hewett J E, Basha I M (1987) Panic attack symptoms in patients with chest pain and angiographically normal coronary arteries. J Anx Dis 1: 41-46
67. Ottervanger J P, van Witsen T B, Valkenberg H A, Stricker B H (1993) Postmarketing study of cardiovascular adverse reactions associated with sumatriptan. BMJ 307: 1185
68. Overo K F (1989) The pharmacokinetic and safety evaluation of citalopram from preclinical and clinical data. In Montgomery S A (ed.), Citalopram, a new antidepressant from Lundbeck. Proceedings of XXII Nordiske Psykiater Kongres Reykjavik. Excerpta Medica, Amsterdam, pp. 22-30
69. Pfeifer M A, Cook D, Brodsky J, Tice D, Reenan A, Sedine S, Halter J B, Porte D Jr (1982) Quantitative evaluation of cardiac parasympathetic activity in normal and diabetic men. Diabetes 31: 339-345
70. Pozzati A, Pancaldi L G, Bugiardini R (1994) Transient sympathovagal unbalance triggers 'ischaemic' sudden death during Holter monitoring. Circulation 90: I-330(abstract)
71. Preskorn S (1993) Pharmacokinetics of antidepressants: why and how they are relevant to treatment. J Clin Psychiat 54 (Suppl. 9): 14-34
72. Preskorn S H, Alderman J, Chung M, Harrison W, Messig M, Harris S (1994) Pharmacokinetics of desipramine coadministered with sertraline or fluoxetine. J Clin Psychopharmac 14: 90-98
73. Rathmann W, Ziegler D, Jahnke M, Haastert B, Gries F A (1993) Mortality in diabetic patients with cardiovascular autonomic neuropathy. Diab Med 10: 820-824
74. Rechlin T (1994) The effect of amitriptyline, doxepine, fluvoxamine, and paroxetine treatment on heart rate variability. J Clin Psychopharmac 14: 392-395
75. Rechlin T, Claus D, Weis M (1994a) Heart rate analysis in 24 patients treated with 150mg amitriptyline per day. Psychopharmacology 116: 110-114
76. Rechlin T, Weis M, Spitzer A, Kaschka W P (1994b) Are affective disorders associated with alterations of heart rate variability? J Affect Dis 32: 271-275
77. Roose S P, Glassman A H, Siris S G, Walsh B T, Bruno R L, Wright L B (1981) Comparison of imipramine- and nortriptyline-induced orthostatic hypotension: a meaningful difference. J Clin Psychopharmac 1: 316-319
78. Roose S P, Glassman A H, Giardina E G V, Walsh B T, Woodring S, Bigger J T (1987) Tricyclic antidepressants in depressed patients with cardiac conduction disease. Archs Gen Psychiat 44: 273-275
79. Rosen S D, Paulesen E, Frith C D, Frackowiak R S, Davis G J, Jones T, Camici P G (1994) Central nervous pathways mediating angina pectoris. Lancet 344: 147-150
80. Rosen S D, Paulesen E, Frackowiak R S, Camici P G (1995) Central correlates of chest pain in syndrome X. Circulation 92: 1651
81. Rudorfer M V, Young R C (1980) Desipramine: cardiovascular effects and plasma levels. Am J Psychiat 137: 984-986
82. Samoil D, Grubb B P (1992) Vasovagal (neurally mediated) syncope: pathophysiologic aspects. Eur J Pacing Electrophysiol 2: 234-241
83. Saxena P R, Villalon CM (1991) 5-HT: a chameleon in the heart. Trends Pharmac Sci 121: 223-227
84. Schleifer S J, Macari-Hinson M M, Coyle D A (1989) The nature and course of depression following myocardial infarction. Arch Intern Med 149: 1785-1789
85. Shrivastava R K, Cohn C, Crowder J, Davidson J, Dunner D, Feighner J, Kiev A, Patrick R (1994) Long-term safety and clinical acceptability of venlafaxine and imipramine in outpatients with major depression. J Clin Psychopharmac 14: 322-329
86. Smyth H S, Sleight P, Pickering G W (1969) Reflex regulation of arterial blood pressure during sleep in man: a quantitative method of assessing baroreflex sensitivity. Circ Res 24: 109
87. Sprangers R L H, Wesseling K H, Imholz A L T, Imholz B P M, Wieling W (1991) The initial blood pressure fall upon stand up and onset to exercise explained by changes in total peripheral resistance. J Appl Physiol 70: 523-530
88. Steptoe A, Vogele C (1990) Cardiac baroreflex function during postural change assessed using non-invasive spontaneous sequence analysis in young men. Cardiovasc Res 24: 627-632
89. Sternbach H (1991) Fluoxetine associated potentiation of calcium-channel blockers. J Clin Psychopharmac 11: 390-391
90. Szabadi E, Gaszner P, Bradshaw C M (1980) The peripheral anticholinergic activity of tricyclic antidepressants: comparison of amitriptyline and desipramine in human volunteers. Br J Psychiat 137: 433-439
91. Szabadi E, Lister B S, Bradshaw C M (1990) Effect of chronic treatment with desipramine on peripheral beta-receptor-mediated responses in man. Eur J Pharmac 183: 161-162(abstract)
92. Task Force of the Working Group on Arrhythmias of the European Society of Cardiology (1991) The Sicilian gambit: a new approach to the classification of antiarrhythmic drugs based on their actions on arrhythmogenic mechanisms. Circulation 84: 1831-1851
93. Taylor D (1995) Selective serotonin reuptake inhibitors and tricyclic antidepressants in combination: interactions and therapeutic uses. Br J Psychiat 167: 575-580
94. Thomson A H, McGovern E M, Bennie P, Caldwell G, Smith P (1992) Interaction between fluvoxamine and theophylline. Pharmaceut J 1: 137
95. Townend J N, Littler W A (1995) Cardiac vagal activity, a target for intervention in heart disease. Lancet 345: 937-938
96. Tulen J H M, de Man K J, Bruijn J A, Pepplinkhuizen L, van den Meiracker A H, Man in't Veld A J (1994) Spectral analysis of fluctuations in heart rate and blood pressure before and after treatment with imipramine or mirtazepine in major depressive disorder. Eur Neuropsychoparmac 4: 328-329(abstract)
97. Van Dellen H J, Aasman J, Mulder L J M, Mulder G (1985) Time domain versus frequency domain measures of heart rate variability. In Orlebeke J F, Mulder G, van Doornen L J P (eds), The psychophysiology of cardiovascular control. Plenum, New York, pp. 353-374
98. Veith R C, Friedel R O, Bloom V, Bielski R (1980) Electrocardiogram changes and plasma desipramine levels during treatment of depression. Clin Pharmac Therap 27: 796-802
99. Veith R C, Raskin M A, Caldwell J H, Barnes R F, Gumbrecht G, Ritchie J L (1982) Cardiovascular effects of tricyclic antidepressants in depressed patients with chronic heart disease. N Engl J Med 306: 954-959
100. Verheyen A, Vlaminckx E, Geuens G, De Clerck F (1994) Does 5-hydroxytryptamine contribute to neointimal proliferation in response to balloon-induced arterial injury in rats? J Serotonin Res 1: 79-84
101. Vybiral T, Bryg R J, Maddens M E (1990) Effects of transdermal scopolamine on heart rate variability in normal subjects. Am J Cardiol 65: 604-608
102. Walley T, Pirmhamed M, Proudlove C, Maxwell D (1993) Interaction of metoprolol and fluoxetine. Lancet 341: 967-968
103. Warrington S J, Dana-Hari J, Sinclair A J (1989) Cardiovascular and psychomotor effects of repeated doses of paroxetine: a comparison study with amitriptyline and placebo in healthy men. Acta Psychiat Scand 80 (Suppl. 350): 42-44
104. Wells K B, Golding J M, Burnham M A (1988) Psychiatric disorder in a sample of the general population with and without chronic medical conditions. Am J Psychiat 145: 976-981
105. Wells K B, Stewart A, Hays R D, Burnam M A, Rogers W, Daniels M, Berry S, Greenfield S, Ware J (1989) The functioning and well-being of depressed patients. JAMA 262: 914-919
106. Wieling W (1992) Non invasive continuous recording of heart rate and blood pressure in the evaluation of neurocardiovascular control. In Bannister R, Mathias C J (eds), Autonomic failure: a textbook of clinical disorders of the autonomic nervous system, 3rd edn. Oxford University Press, Oxford, pp. 291-311
107. Wilner K D, Lzar J D, Apseloff G (1991) The effects of sertraline on the pharmacodynamics of warfarin in healthy volunteers. Biol Psychiat 29: 354S-355S(abstract)
108. Wilson S J, Lillywhite A R, Coupland N J, Potokar J, Bailey J E, Nutt D (1993) Effects of fluvoxamine and clomipramine treatment on beat-by-beat changes in blood pressure during standing. Eur Neuropsychopharmac 3: 440-441(abstract)
109. Wilson W H, Higano H, Papadatos Y, Kelwala S, Ban T A (1983) A double-blind placebo-controlled study to compare the autonomic effects of fluvoxamine with those of amitriptyline and doxepin in healthy volunteers. Br J Clin Pharmac 15: 385S-392S
110. Wise M G, Taylor S E (1990) Anxiety and mood disorders in medically ill patients. J Clin Psychiat 51: 27-32
111. Woolfrey S, Gammack N S, Dewar M S, Brown P J E (1993) Fluoxetine-warfarin interaction. BMJ 307: 241
112. Yeragani V K, Meiri P, Balon R, Pohl R, Golec S (1990) Effect of imipramine treatment on changes in heart rate and blood pressure during postural and isometric handgrip tests. Eur J Clin Pharmac 38: 139-144
113. Yeragani V K, Pohl R, Balon R, Ramesh C, Glitz D, Jung I, Sherwood P (1991) Heart rate variability in patients with major depression. Psychiat Res 37: 35-46
114. Yeragani V K, Pohl R, Balon R, Ramesh C, Glitz D, Weinberg P, Merlos B (1992a) Effect of imipramine treatment on heart rate variability measures. Neuropsychobiology 26: 27-32
115. Yeragani V K, Berger R, Pohl R, Srinivasan K, Balon R, Ramesh C, Weinberg P, Berchou R (1992b) Effects of yohimbine on heart rate variability in panic disorder patients and normal controls: a study of power spectral analysis of heart rate. J Cardiovasc Pharmac 20: 609-618
116. Yeragani V K, Pohl R, Berger R Balon R, Ramesh C, Glitz D, Srinavsan K, Weinberg P (1993) Decreased heart rate variability in panic disorder patients: a study of power spectral analysis of heart rate. Psychiat Res 46: 89-103
117. Yeragani V K, Srinivasan K, Pohl R, Berger R, Balon R, Ramesh C (1994) Effects of nortriptyline on heart rate variability in panic disorder patients: a preliminary study using power spectral analysis of heart rate. Neuropsychobiology 29: 1-7